This excerpt taken from the EYE 8-K filed Feb 10, 2009.
SANTA ANA, Calif., Feb. 9, 2009 -- Advanced Medical Optics, Inc. (AMO) [NYSE:EYE], announced today that, in connection with its previously announced cash tender offer for its outstanding 7½% Senior Subordinated Notes due 2017 (the “Notes”) (CUSIP No. 00763MAN8, ISIN No. US00763MAN83) and the related consent solicitation to amend the indenture governing the Notes, it has amended the offer to increase the Total Consideration and extend the Consent Deadline (as such terms are defined in the Offer to Purchase and Consent Solicitation Statement dated Jan. 27, 2009 (the “Offer to Purchase”) and the related Letter of Transmittal and Consent).
The expiration time of the tender offer remains midnight EST on Tuesday, Feb. 24, 2009, unless extended or earlier terminated (the “Expiration Time”). The new Consent Deadline is midnight EST on Feb. 24, 2009, the same time as the Expiration Time, unless further extended or earlier terminated.
The Total Consideration to be paid for Notes that are validly tendered and not validly withdrawn at or prior to the Expiration Time has been increased to $